EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity

Hajnalka Lőrincz iD, Sára Csiha, Balázs Ratku iD, Sándor Somodi, Ferenc Sztanek, György Paragh, Mariann Harangi iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25116264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hajnalka Lőrincz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Serpins, Obesity, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office - NKFIH, Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, Eötvös Loránd Research Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kallistatin is an endogenous serine proteinase inhibitor with various functions, including antioxidative, anti-inflammatory, and anti-atherosclerotic properties. To date, associations between kallistatin and lipoprotein subfractions are poorly investigated. In this study, we enrolled 62 obese patients with type 2 diabetes (T2D), 106 nondiabetic obese (NDO) subjects matched in gender, age, and body mass index, as well as 49 gender- and age-matched healthy, normal-weight controls. Serum kallistatin levels were measured with ELISA, and lipoprotein subfractions were analyzed using Lipoprint® (Quantimetrix Corp., Redondo Beach, CA, USA) gel electrophoresis. Kallistatin concentrations were significantly higher in T2D patients compared to NDO and control groups. We found significant positive correlations between very-low-density lipoprotein (VLDL), small high-density lipoprotein (HDL) subfractions, glucose, hemoglobin A1c (HbA1c), betatrophin, and kallistatin, while negative correlations were detected between mean low-density lipoprotein (LDL) size, large and intermediate HDL subfractions, and kallistatin in the whole study population. The best predictor of kallistatin was HbA1c in T2D patients, high-sensitivity C-reactive protein (hsCRP) and betatrophin in NDO patients, and hsCRP in controls. Our results indicate that kallistatin expression might be induced by persistent hyperglycemia in T2D, while in nondiabetic subjects, its production might be associated with systemic inflammation. The correlation of kallistatin with lipid subfractions may suggest its putative role in atherogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2SerpinsObesityBiomarkersInflammationHumansMaleFemaleMiddle AgedBlood GlucoseLipoproteinsHomeostasisAdultGlycated HemoglobinCase-Control StudiesAgedC-Reactive Protein

Stichwörter der Autor:innen

betatrophindiabeteskallistatinlipid subfractionsobesitytriglyceride

Substanzen

kallistatinSerpinsBiomarkersBlood GlucoseLipoproteinsGlycated HemoglobinC-Reactive Protein

Autor:innen und Institutionen

  • Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
  • Doctoral School of Health Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
  • Department of Emergency Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
  • Institute of Health Studies, Faculty of Health Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
  • ELKH-UD Vascular Pathophysiology Research Group 11003, University of Debrecen, H-4032 Debrecen, Hungary.

ORCID-Profile: Hajnalka Lőrincz, Balázs Ratku, Mariann Harangi

Förderung

  • National Research, Development and Innovation Office - NKFIH
  • Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund
  • Eötvös Loránd Research Network
  • National Research, Development, and Innovation Office—NKFIH
  • Ministry of Innovation and Technology of Hungary
  • National Research, Development, and Innovation Fund

Zitieren

APA

Lőrincz, H., Csiha, S., Ratku, B., Somodi, S., Sztanek, F., Paragh, G., & Harangi, M. (2024). Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116264

Vancouver

Lőrincz H, Csiha S, Ratku B, Somodi S, Sztanek F, Paragh G, et al. Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116264

BibTeX
@article{Lrincz2024,
  author = {Lőrincz, Hajnalka and Csiha, Sára and Ratku, Balázs and Somodi, Sándor and Sztanek, Ferenc and Paragh, György and Harangi, Mariann},
  title = {Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25116264}
}
Kostenlos starten →